Germany-based Leica Biosystems is set to introduce new Aperio VERSA scanner at the American Association for Cancer Research (AACR) annual meeting in Philadelphia, US, which is being held from 18 to 22 April.
Part of the Aperio scanner family, Aperio VERSA is a combination digital pathology research scanner for brightfield, fluorescence and FISH imaging.
Leica Biosystems pathology imaging business general manager and vice president Puneet Sarin said: "The Aperio VERSA is a breakthrough for researchers searching for an affordable solution for their diverse imaging needs.
"This combined introduction of solutions, from advanced staining, to imaging and computerized image analysis, demonstrates our commitment to provide cutting-edge technology to drive new breakthroughs in biomarker discovery."
The new scanner is said to offer high levels of automation and an optional 200 slide autoloader enable unsupervised batch processing from low magnification to high resolution, oil-immersion scanning.
At the event, the company will also launch a new ISH algorithm and the latest version of Aperio eSlide Manager.
The ISH algorithm has been developed to detect and quantify single or dual brightfield in-situ hybridization markers and is optimized for samples stained on the BOND RX, Leica Biosystems fully automated research advanced staining platform.
According to the company, scanned slides can be accessed through the Aperio eSlide Manager web or client viewers, which will allow the optimal and high-speed viewing experience for multi-channel and z-stack fluorescent images.
Image: Leica Biosystems will launch new Aperio VERSA scanner at AACR 2015. Photo: courtesy of Leica Biosystems Nussloch GmbH.